Patent · US Active

Pyrrolobenzodiazepine-antibody conjugates

US10799596B2 · kind B2 · utility

1Cited by

79References

12Claims

0Family size

Assignees

ADC THERAPEUTICS SA · CH
MedImmune Limited · US

Inventors

Patricius Hendrikus Cornelis Van Berkel · Épalinges, CH
Philip Wilson Howard · London, GB

Key dates

Filing date	Mar 5, 2018
Grant date	Oct 13, 2020
Priority date	—
Expiry date	Aug 23, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/565
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Conjugates of an antibody that binds to CD25 with PBD dimers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.